Freiburg registry for parkinsonian syndroms and dementias

Freiburg registry for parkinsonian syndroms and dementias - FReePD

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00017454

Enrollment

2000

Registered

2019-06-12

Start date

2019-06-13

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G20 G23.9 G23.2 G23.1 G31.82 G30 G31.0 G91.2 G23.3 I67.3

Interventions

Group 1: In this study all clinical findings and reports of additional diagnostics are stored in a database. Additionally every patient receives video documentation of a physical examination as well a

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Presentation of a parkinson syndrome or a dementia in one of the participating study centers

Exclusion criteria

Exclusion criteria: No possibility for oral and written consent

Design outcomes

Primary

Measure	Time frame
Comparison of different imaging modalities in the diagnosis of parkinson syndromes and dementias	—

Secondary

Measure	Time frame
- association of findings of different imaging modalities with clinical phenotypes - Comparison of different imaging modalities regarding the prognosis of parkinson syndromes and dementias - Using an interdisciplinary approach, further specific phenotypes of parkinson syndromes and dementias can be investigated - Assessment of the sensitivity and specificity of magnetic resonance imaging (MRI) in the differentiation between Parkinson's disease, atypical Parkinson syndromes and dementia in the course of the disease - Assessment of sensitivity and specificity of MRI in the differentiation between multisystem atrophy, progressive supranuclear palsy, corticobasal degeneration - Determining the quality of video-assisted and algorithm-based movement analysis in the differentiation of parkinsonian syndromes and dementias - Association of the findings of the movement analysis with atrophy patterns or altered metabolism in cerebral imaging - Determination of the value of optical coherence tomography and optical coherence tomography angiography in the differentiation of parkinson syndromes and dementias	—

Measure

Time frame

- association of findings of different imaging modalities with clinical phenotypes - Comparison of different imaging modalities regarding the prognosis of parkinson syndromes and dementias - Using an interdisciplinary approach, further specific phenotypes of parkinson syndromes and dementias can be investigated - Assessment of the sensitivity and specificity of magnetic resonance imaging (MRI) in the differentiation between Parkinson's disease, atypical Parkinson syndromes and dementia in the course of the disease - Assessment of sensitivity and specificity of MRI in the differentiation between multisystem atrophy, progressive supranuclear palsy, corticobasal degeneration - Determining the quality of video-assisted and algorithm-based movement analysis in the differentiation of parkinsonian syndromes and dementias - Association of the findings of the movement analysis with atrophy patterns or altered metabolism in cerebral imaging - Determination of the value of optical coherence tomography and optical coherence tomography angiography in the differentiation of parkinson syndromes and dementias

—

Countries

Germany

Contacts

Public ContactNils Schröter

Klinik für NeurologieUniversitätsklinikum Freiburg

nils.schroeter@uniklinik-freiburg.de0761-270-50010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026